Abstract
The results of epidemiological studies, now based mainly on ultrasound screening, tell us that in developed societies the prevalence of gallstones is approximately 10%l .When combined with clinical assessment they also tell us that approximately two-thirds of gallstone carriers are unaware that they have stones2 3. In other words, the majority of gallstones diagnosed in this way are silent or asymptomatic. Indirect support for the concept that ‘the innocent gallstone is not a myth’4 comes from comparisons between prevalence rates for cholelithiasis and cholecystectomy rates in any given community. Even though the frequency with which cholecystectomy is carried out varies considerably from country to country5, and despite the fact that surgical removal of the gallbladder is now the most common abdominal operation performed in Western society6, it is clear that only a minority of gallstone carriers will ever come to surgery. By inference, therefore, the majority of patients with cholelithiasis are either unaware of their stones or have related symptoms which the patient, the doctor (or both) judge to be tolerable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ingelfinger, F. J. (1968). Digestive disease as a national problem. V. Gallstones. Gastroenterology, 55, 102–104
Ricci, G. (1983). The Grepco Study: aims, methodology and prevalence data. In Abstracts of International Workshop on Epidemiology and Prevention of Gallstone Disease, Rome, December 1983
Barbara, L. (1983). Epidemiology of gallstone disease: the Sirmione Study. In Abstracts of International Workshop on Epidemiology and Prevention of Gallstone Disease, Rome, December 1983
Gracie, W. A. and Ransohoff, D. F. (1982). The natural history of silent gallstones: the innocent gallstone is not a myth. N. Engl. J. Med., 307, 798–800
Fisher, M. M. (1979). Perspectives in gallstones. In Fisher, M. M., Goresky, C. A., Shaffer, E. A. and Strasberg, S. M. (eds.) Gallstones, pp. 1–17. ( New York: Plenum )
Holland, C. and Heaton, K. W. (1972). Increasing frequency of gallbladder operations in the Bristol clinical area. Br. Med. J., 3, 672–675
Lund, J. (1960). Surgical indications in cholelithiasis: prophylactic cholecystectomy elucidated on the basis of long-term follow-up on 526 non operated cases. Ann. Surg., 151, 153–162
Wenckert, A. and Robertson, B. (1966). The natural course of gallstone disease. Eleven-year review of 871 nonoperated cases. Gastroenterology, 50, 376–381
Donaldson, R. M. Jr (1982). Advice for the patient with ‘silent’ gallstones. N. Engl J. Med., 307, 815–817
Dowling, R. H. (1982). Cholelithiasis: medical treatment. Clin. Gastroenterol., 12, 125–178
Northfield, T. C., LaRusso, N. F., Hofmann, A. F. and Thistle, J. L. (19 75). Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut, 16, 12–17
von Bergmann, K., Gutsfeld, M., Schulze-Hagen, K. and von Unruh, G. (1979). Effects of ursodeoxycholic acid on biliary lipid secretion in patients with radiolucent gallstones. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Biological Effects of Bile Acids, pp. 61–66. ( Lancaster: MTP Press )
Thistle, J. L. and Schoenfield, L. J. (1971). Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology, 61, 488–496
Maton, P. N., Murphy, G. M. and Dowling, R. H. (1977). Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet, 2, 1297–1301
Schoenfield, L. J., Lachin, J. M., the NCGS Steering Committee and the NCGS Group (1981). National Cooperative Gallstone Study: A controlled trial of the efficacy and safety of chenodeoxycholic acid for dissolution of gallstones. Ann. Intern. Med., 95, 257–282
Leuschner, U. (1977). Dissolution of biliary cholesterol calculi using chenodeoxycholic acid. Internist, 18, 114–115
Leuschner, U., Leuschner, M. and Stromm, W. D. (1982). Our 10 years’ experience in gallstone dissolution. Comparison with the National Cooperative Gallstone (NCGS, USA) and the Tokyo Cooperative Gallstone Study (TCGS, Japan). Gastroenterology, 80, 1113 (abstract)
Maton, P. N., Iser, J. H., Reuben, A., Saxton, H. M., Murphy, G. M. and Dowling, R. H. (1982). The final outcome of CDCA-treatment in 12 5 patients with radiolucent gallstones: factors influencing efficacy withdrawal, symptoms and side effects and post-dissolution recurrence. Medicine (Baltimore), 61, 85–96
Dowling, R. H., Hofmann, A. F. and Barbara, L. (1978). Workshop on Ursodeoxycholic Acid. ( Lancaster: MTP Press )
Bachrach, W. H. and Hofmann, A. F. (1982). Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis: a review. Dig. Dis. Sci., 27, 737–761
Tokyo Cooperative Gallstone Study Group (1980). Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. Gastroenterologic, 78, 542–548
Bateson, M. C., Bouchier, I. A. D., Trash, D. B., Maudgal, D. P. and Northfield, T. C. (1981). Calcification of radiolucent gall stones during treatment with ursodeoxycholic acid. Br. Med. J., 283, 645–656
Raedsch, R., Stiehl, A. and Cyzgan, P. (1983). Ursodeoxycholic acid and gallstone calcification. Lancet, 2, 1296 (Letter to editor)
Gleeson, D., Ruppin, D. C., Murphy, G. M. and Dowling, R. H. (1983). Second look at ursodeoxycholic acid (UDCA): high efficacy for partial but low efficacy for complete gallstone dissolution, and a high rate of acquired stone opacification. Gut, 24, A999–A1000 (abstract)
Whiting, M., Jarvinen, V. and Watts, J. (1980). Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid. Gut, 21, 1077–1081
Sarva, R., Farivar, S., Fromm, H. and Poller, W. (1981). Study of the sensitivity and specificity of computerized tomography in the detection of calcified gallstones which appear radiolucent by conventional roentgenography. Gastrointest. Radiol., 6, 165–167
Roda, E., Bazzoli, F. and Labate, A. M. M. (1982). Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology, 2, 804–810
Fromm, H., Roat, J. W., Gonzalez, V., Sarva, R. P. and Farivar, S. (1983). Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. Gastroenterology, 85, 1257–1264
Ruppin, D. C., Maton, P. N., Williams, G. V., Merdith, T. J., Murphy, G. M., and Dowling, R. H. (1982). Ursotherapy for cholesterol gallstones? Ital. J. Gastroenterol., 15, (abstract; in press)
Somerville, K. W., Rose, D. H. and Bell, G. D. (1982). Gall-stone dissolution and recurrence: are we being misled? Br. Med. J., 284, 1295–1297
Shapero, T. F., Rosen, I. E., Milson, S. R. and Fisher, M. M. (1982). Discrepancy between ultrasound and oral cholecystography in the assessment of gallstone dissolution. Hepatology, 2, 587–590.
Baddley, H., Nolan, D. J. and Slamon, P. R. (1978). Radiological Atlas of Biliary and Pancreatic Disease. ( Aylesbury: HM&M )
Jacobus, D. P., Trout, J. R., Greenwell, B. E., Schoenfield, L. J. and Lachin, J. M. (1983). The natural history and the therapeutic response to Chenodiol in patients with floatable stones in the National Co-operative Gallstone Study (NCGS). Gastroenterology, 84, 1197 (abstract)
Dumont, M., Erlinger, S. and Uchman, S. (1980). Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat. Possible role of bicarbonate transport. Gastroenterology, 79, 82–89
Batta, A. K., Salen, G., Shefer, S., Tint, G. S. and Dayal, B. (1982). The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile açid composition. Hepatology, 2, 811–816
Bell, G. D., Dowling, R. H., Whitney, B. and Sutor, D. J. (1975). The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut, 16, 359–364.
Trotman, B. W., Petrella, E. J., Soloway, R. D., Sanchez, H., Morris, T. A., III and Miller, W. T. (1975). Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology, 68, 1563–1566
Bruusgaard, A., Sorensen, T. I. A., Justensen, T. and Krag, E. (1976). Bile acid metabolism after jejunoileal bypass operation for obesity. Scand. J. Gastroenterol., 11, 833–838
Maton, P. N., Murphy, G. M. and Dowling, R. H. (1980). Lack of response to chenodeoxycholic acid in obese and non-obese patients. Gut, 21, 1082–1086
Fisher, M. M., Roberts, E. A., Rosen, I. E. and Wilson, S. R. (1982). The efficacy of chenodeoxycholic acid in the dissolution of gallstones. In Bile Acids and Cholesterol in Health and Disease. I. Abstracts, 7th International Bile Acid Meeting, Basel, pp. 256–257
Gleeson, D., Ruppin, D. C. and Dowling, R. H. (1983). British Gallstone Study Group (BGSG) post-dissolution trial: interim report on overall recurrence rates and discrepancies between ultrasonography (US) and oral cholecystography (OCG). Gut, 24, A1006 (abstract)
Ruppin, D. C. and Dowling, R. H. (1982). Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet, 1, 181–185
Toulet, J., Rousselet, J., Viteau, J.-M., Duchon, Y., Pagniez, R., Samain, B. and Vienne, J.-L. (1983). Récidives et prévention des récidives après dissolution de la lithiase vésiculaire par l’acide chénodésoxycholique chez 22 patients. Gastroenterol. Clin. Biol., 7, 605–609
Thistle, J. L. (1981). Medical treatment of gallstones. Pract. Gastroenterol., 5, 31–38
Editor information
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Dowling, R.H. (1984). Epidemiology and medical treatment of cholesterol gallstones: recurrence, post-dissolution management and the future. In: Capocaccia, L., Ricci, G., Angelico, F., Angelico, M., Attili, A.F. (eds) Epidemiology and Prevention of Gallstone Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5606-3_17
Download citation
DOI: https://doi.org/10.1007/978-94-009-5606-3_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8972-2
Online ISBN: 978-94-009-5606-3
eBook Packages: Springer Book Archive